K Camphausen
Overview
Explore the profile of K Camphausen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
253
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sproull M, Camphausen K
Radiat Res
. 2025 Feb;
203(3):129-141.
PMID: 39923796
The events of 9/11 sparked a revitalization of civil defense in the U.S. for emergency planning and preparedness for future radiological or nuclear event scenarios and specifically for mass casualty...
2.
Sproull M, Fan Y, Chen Q, Meerzaman D, Camphausen K
Radiat Res
. 2024 Sep;
202(4):697-705.
PMID: 39222930
In future mass casualty medical management scenarios involving radiation injury, medical diagnostics to both identify those who have been exposed and the level of exposure will be needed. As almost...
3.
Sproull M, Fan Y, Chen Q, Meerzaman D, Camphausen K
Radiat Res
. 2024 Apr;
201(6):558-566.
PMID: 38684463
There is a need for point-of-care diagnostics for future mass casualty events involving radiation exposure. The development of radiation exposure and dose prediction algorithms for biodosimetry is needed for screening...
4.
Jagasia S, Tasci E, Zhuge Y, Camphausen K, Krauze A
Expert Rev Precis Med Drug Dev
. 2023 Nov;
8(1):33-42.
PMID: 37982134
Introduction: Radiation therapy (RT) is commonly used to treat cancer in conjunction with chemotherapy, immunotherapy, and targeted therapies. Despite the effectiveness of RT, tumor recurrence due to treatment resistance still...
5.
Sproull M, Wilson E, Miller R, Camphausen K
Radiat Res
. 2023 May;
200(1):80-91.
PMID: 37141143
The discovery of X rays in the late 19th century heralded the beginning of a new age in medicine, and the advent of channeling the power of radiation to diagnose...
6.
Sproull M, Kawai T, Krauze A, Shankavaram U, Camphausen K
Radiat Res
. 2022 Sep;
198(6):573-581.
PMID: 36136739
There is a need to identify new biomarkers of radiation exposure for not only systemic total-body irradiation (TBI) but also to characterize partial-body irradiation and organ specific radiation injury. In...
7.
Krauze A, Zhuge Y, Zhao R, Tasci E, Camphausen K
J Biotechnol Biomed
. 2022 Feb;
5(1):1-19.
PMID: 35106480
The interpretation of imaging in medicine in general and in oncology specifically remains problematic due to several limitations which include the need to incorporate detailed clinical history, patient and disease-specific...
8.
Krauze A, Megan M, Theresa C, Peter M, Shih J, Tofilon P, et al.
Cancer Stud Ther
. 2021 Oct;
5(1).
PMID: 34621499
Purpose/objectives: Valproic Acid (VPA) is an antiepileptic agent with HDACi (histone deacetylase inhibitor) activity shown to radiosensitize glioblastoma (GBM) cells. We evaluated the addition of VPA to standard radiation therapy...
9.
Zibly Z, Cohen Z, Peled A, Zach L, Nissim U, Attia M, et al.
J Clin Neurosci
. 2020 Dec;
82(Pt A):162-165.
PMID: 33317726
Hemangioblastomas (HB) are benign low grade vascular tumors most frequently occurring in the cerebellum, brain stem, and spinal cord. Often associated with Von Hippel Lindau disease (VHL), the lesions are...
10.
Dan T, Hewitt S, Ohri N, Ly D, Soule B, Smith S, et al.
Breast Cancer Res Treat
. 2013 Nov;
143(1):11-8.
PMID: 24276281
CD44 is a transmembrane glycoprotein involved in numerous cellular functions, including cell adhesion and extracellular matrix interactions. It is known to be functionally diverse, with alternative splice variants increasingly implicated...